Nippon India Pharma Fund
Direct · Growth ₹609.41
19 Jun 2026
NAV
17.1%
3Y CAGR
16.7%
5Y CAGR
16.3%
10Y CAGR
17.2%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
6.69
Sharpe
-24.0%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.67 L | 20.8% | -27.3% | 94.0% |
| 3 Years | ₹36.00 L | ₹45.22 L | 16.9% | -7.0% | 44.9% |
| 5 Years | ₹60.00 L | ₹93.09 L | 17.0% | -2.2% | 30.1% |
| 7 Years | ₹84.00 L | ₹1.63 Cr | 18.5% | 3.1% | 27.0% |
| 10 Years | ₹1.20 Cr | ₹3.13 Cr | 17.9% | 12.9% | 21.5% |
| 12 Years | ₹1.44 Cr | ₹4.46 Cr | 17.8% | 15.7% | 20.2% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 20.8% | 14.5% | 13.6% | +6.3% |
| 3 Years | 16.9% | 11.2% | 17.4% | +5.7% |
| 5 Years | 17.0% | 10.5% | 17.1% | +6.5% |
| 7 Years | 18.5% | 10.6% | 16.6% | +7.9% |
| 10 Years | 17.9% | 11.5% | 16.9% | +6.4% |
| 12 Years | 17.8% | 11.4% | 16.6% | +6.4% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 20.4% | 13.8% | -15.1% | 90.7% | 0.59 | 2.19 | 76% | — | — |
| 3 Years | 17.1% | 20.0% | -1.3% | 32.2% | 1.17 | 5.41 | 99% | — | — |
| 5 Years | 16.7% | 16.8% | 0.0% | 32.1% | 1.61 | 15.76 | 100% | — | — |
| 10 Years | 16.3% | 16.2% | 13.1% | 18.8% | 6.69 | — | 100% | — | — |
-24.0%
Max Drawdown
19 mo
Drawdown Duration
15 mo
Recovery Time
-6.4%
Avg Drawdown
Calmar Ratio by Duration
0.85
1Y
0.71
3Y
0.69
5Y
0.70
7Y
0.68
10Y
0.76
12Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +8.25 | 0.59 | 69.3% | 55.7% | 9.0% | -3.1% |
| 3 Years | +14.33 | 0.56 | 70.5% | 49.4% | 22.0% | 8.6% |
| 5 Years | +6.24 | 0.55 | 60.7% | 49.4% | 14.0% | 8.8% |
| 7 Years | +13.91 | 0.53 | 60.8% | 43.9% | 22.7% | 10.8% |
| 10 Years | +7.24 | 0.55 | 62.8% | 51.7% | 16.4% | 11.3% |
| 12 Years | +8.44 | 0.56 | 64.3% | 52.0% | 17.0% | 10.1% |
| 15 Years | +7.26 | 0.54 | 62.5% | 50.1% | 15.5% | 9.7% |
33
Total Holdings
58.8%
Top 10 Weight
3
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 13.35% |
| 2 | Lupin Limited | 7.31% |
| 3 | Dr. Reddy's Laboratories Limited | 6.72% |
| 4 | Cipla Limited | 6.16% |
| 5 | Divi's Laboratories Limited | 5.80% |
| 6 | Apollo Hospitals Enterprise Limited | 5.20% |
| 7 | Mankind Pharma Limited | 3.94% |
| 8 | MedPlus Health Services Limited | 3.68% |
| 9 | Sai Life Sciences Limited | 3.43% |
| 10 | Ajanta Pharma Limited | 3.21% |